CXCR4 antagonists as HIV entry inhibitors

Katrien Princen; Sigrid Hatse; Kurt Vermeire; Gary Bridger; Renato T. Skerlj; De Clercq Erik; Dominique Schols

Article2012

Recent Progress in Small Molecule CCR5 Antagonists as Potential HIV-1 Entry Inhibitors

Wenwen Chen, Peng Zhan, De Clercq Erik, Xinyong Liu

Article2005

AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor

Sigrid Hatse, Katrien Princen, De Clercq Erik, Mette M. Rosenkilde, Thue W. Schwartz, Pedro E. Hernandez-Abad, Renato T. Skerlj, Gary Bridger, Dominique Schols

Article2011

Design of novel CXCR4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication

Renato T. Skerlj, Gary Bridger, Ernest J. McEachern, Curtis Harwig, Christopher R. Smith, Alan Matthew Kaller, D. R. VEALE, Helen S. Yee, Krystyna A. Skupinska, Rossana Wauthy, Letian Wang, Ian R. Baird, Yongbao Zhu, Kate Burrage, Wen Yang, Michael Sartori, Dana Huskens, De Clercq Erik, Dominique Schols

Article2003

Reduced Fitness of HIV-1 Resistant to Cxcr4 Antagonists

Mercedes Armand‐Ugón, Miguel E. Quiñones‐Mateu, Arantxa Gutiérrez, Jordi Barretina, Julià Blanco, Dominique Schols, De Clercq Erik, Bonaventura Clotet, José A. Esté

Article2002

HIV entry as antiviral strategy

Myriam Witvrouw, De Clercq Erik

CXCR4 antagonists as HIV entry inhibitors

Discussion(0)

Related publications

Recent Progress in Small Molecule CCR5 Antagonists as Potential HIV-1 Entry Inhibitors

AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor

Design of novel CXCR4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication

Reduced Fitness of HIV-1 Resistant to Cxcr4 Antagonists

HIV entry as antiviral strategy